Trial
NCT04906213
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
—
Condition
Kidney Transplant
Intervention
Empagliflozin10Mg Tab
Why stopped
The study closed per PI decision due to completion of the biopsy substudy and slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-27